SALT LAKE CITY--(BUSINESS WIRE)--Please replace the release dated Jan. 27, 2026 with the following corrected version due to revisions in headline and subhead. The updated release reads: REPOSITRAK AND NATIONAL GROCERS ASSOCIATION DEEPEN PARTNERSHIP TO STRENGTHEN INDEPENDENT GROCERS' PROFITABILITY AND COMPLIANCE READINESS New collaboration delivers exclusive education and tools to help independents unlock cash, reduce risk, and stay ahead of regulatory change ReposiTrak (NYSE: TRAK), the industr. ...

Company Overview - ReposiTrak, Inc. (TRAK) is a microcap SaaS (software-as-a-service) company that provides technology solutions for retailers and suppliers to comply with supply chain regulations, enhance food safety, and monitor product tracking throughout the supply chain [1] Investment Focus - The analysis primarily concentrates on small- to mid-cap companies, which are often overlooked by many investors, while occasionally reviewing large-cap companies to provide a comprehensive view of the broader equity markets [1]

Group 1 - ReposiTrak, Inc. has initiated a $2 million share repurchase under a Rule 10b5-1 trading plan, part of a broader $21 million stock buyback program [1][2] - The company had approximately $7.6 million remaining under its total repurchase authorization as of December 1 [2] - ReposiTrak specializes in compliance, safety, and supply chain automation platforms for the food, retail, and healthcare sectors, with a customer network across North America [3] Group 2 - The share repurchase will be conducted by the company's broker, depending on market conditions and legal requirements, with no specific target share count or expiration period disclosed [2] - The company did not elaborate on the strategic intent or timing of the new buyback tranche, indicating it will proceed under SEC Rules 10b5-1 and 10b-18 [2]

Core Insights - ReposiTrak is expanding its Traceability Network by adding food manufacturing companies to enhance traceability data sharing in the food supply chain [1][2] - The urgency for food manufacturers to adopt traceability is driven more by customer demands than by FDA deadlines, with retailers and wholesalers requiring data sharing sooner [3] Group 1: Company Developments - ReposiTrak has announced the inclusion of various food manufacturers, including a contract manufacturer of private-label grocery items, a cheese and dairy solutions provider, a gourmet food producer, and a natural wellness brand [2][3] - The ReposiTrak Traceability Network allows for the efficient exchange of FDA-required Key Data Elements (KDEs) for each Critical Tracking Event (CTE) in the supply chain [1][9] Group 2: Industry Trends - Retailers, wholesalers, and restaurants are increasingly demanding traceability data, which can take months for manufacturers to onboard and share accurately [3] - The ReposiTrak platform requires no additional hardware and employs a 500+ point error detection process to ensure data accuracy before it reaches customers [3]

Financial Performance - Total revenue for Q1 fiscal 2026 increased by 10% to $6.0 million, compared to $5.4 million in Q1 fiscal 2025[5] - GAAP net income rose by 9% to $1.8 million, up from $1.7 million in the prior year[5] - Earnings per share (EPS) increased by 13% to $0.09 per diluted share, compared to $0.08 per diluted share in the previous year[5] - Operating income for the quarter increased by 28% to $1.9 million from $1.5 million year-over-year[6] - Net income for the three months ended September 30, 2025, was $1,819,529, an increase of 9.2% compared to $1,665,155 in 2024[19] Revenue Composition - Recurring revenue accounted for approximately 99% of total revenue[6] Cash and Liquidity - The company ended the quarter with $28.8 million in cash and no bank debt[10] - Cash generated from operations was $1.5 million during the quarter[6] - Cash and cash equivalents at the end of the period increased to $28,794,806, up from $25,790,206, representing a growth of 7.8%[19] - Net cash provided by operating activities decreased to $1,538,447 from $1,868,900, reflecting a decline of 17.6% year-over-year[19] Shareholder Returns - The board declared a quarterly dividend of $0.02 per share, representing a 10% increase since the last dividend declaration[6] - Common stock buyback amounted to $149,985, indicating a commitment to returning value to shareholders[19] - Dividends paid decreased slightly to $402,917 from $422,954, a reduction of 4.7% year-over-year[19] - The company has approximately $7.8 million remaining of the $21 million total common share buyback authorization[8] Expenses and Investments - Cash paid for income taxes rose significantly to $536,561, compared to $312,098 in the previous year, marking an increase of 72.2%[19] - The company reported a bad debt expense of $225,000, which is a 50% increase from $150,000 in the prior year[19] - The purchase of property and equipment was $11,750, reflecting ongoing investment in operational capacity[19] Financing Activities - The company experienced a net cash used in financing activities of $1,292,087, compared to $1,266,642 in the previous year, indicating a slight increase of 2%[19] - The company redeemed 70,093 preferred shares for a total of $749,995 during the quarter[7] Accounts Receivable - The company reported a decrease in accounts receivables by $245,439, compared to a decrease of $259,388 in the previous year[19]

Revenue and Income - Revenue for the three months ended September 30, 2025, was $5,971,467, representing a 10% increase from $5,441,142 in the same period of 2024[83] - Net other income increased by 12% to $375,655 for the three months ended September 30, 2025, compared to $335,094 in 2024[90] Expenses - Cost of services and product support decreased by 1% to $854,152 for the three months ended September 30, 2025, compared to $859,219 in 2024[85] - Sales and marketing expenses increased by 5% to $1,607,469 for the three months ended September 30, 2025, up from $1,529,100 in 2024[86] - General and administrative expenses rose by 6% to $1,372,227 for the three months ended September 30, 2025, compared to $1,292,551 in 2024[88] - Depreciation and amortization expense decreased by 13% to $243,746 for the three months ended September 30, 2025, down from $280,211 in 2024[89] Cash Flow and Investments - Net cash provided by operating activities was $1,538,447 for the three months ended September 30, 2025, an 18% decrease from $1,868,900 in the same period of 2024[96] - Net cash used in investing activities was $(20,359) for the three months ended September 30, 2025, compared to cash provided of $34,086 in the same period of 2024, reflecting a 160% variance[97] - Net cash used in financing activities totaled $1,292,087 for the three months ended September 30, 2025, a 2% increase from $1,266,642 in the same period of 2024, due to increased stock buybacks and continued redemption of Preferred Stock[99] Assets and Liabilities - Cash and cash equivalents increased by 1% to $28,794,806 as of September 30, 2025, compared to $28,568,805 as of June 30, 2025, primarily due to higher revenue and cash receipts from customers[94][95] - Current assets increased to $34,114,277 as of September 30, 2025, up 1% from $33,685,800 as of June 30, 2025[101] - Current liabilities decreased by 6% to $5,214,500 as of September 30, 2025, compared to $5,531,118 as of June 30, 2025[102] Dividends and Stock - The company declared a quarterly cash dividend of $0.02 per share, representing an annual dividend yield of approximately 0.54%[76] - The Company declared a quarterly cash dividend of $0.01 per share for the quarter ending September 30, 2025, representing a 10% increase from the previous dividend[105] - A total of 571,772 shares of Preferred Stock have been redeemed at a total cost of $6,117,960, with $2.85 million of Preferred Stock remaining to be redeemed[106] - Preferred dividends decreased to $58,817 for the three months ended September 30, 2025, down 45% from $107,882 in the same period of 2024[91] Company Strategy and Operations - The company’s growth in traceability services is driven by increased regulatory requirements and consumer response to food safety hazards[83] - The company is focusing on recurring subscription revenue, with less emphasis on transactional revenue[84] - The ReposiTrak Traceability Network is positioned to provide end-to-end traceability, connecting thousands of suppliers and retailers[81] Financial Position and Accounting - The Company had zero bank debt as of September 30, 2025, following the termination of its credit facility in March 2024[104] - The company adopted new accounting standards effective July 1, 2019, with no material changes to revenue recognition practices compared to previous periods[117] - The effective annual percentage rate (APR) for capital leases is 4.55%, with total lease obligations depreciated on a three-year straight-line basis, costing less than $400,000[124] - As of September 30, 2025, the fair value of cash holdings is $28,794,806, with a weighted average interest rate of 4.71%[125] - The company does not engage in hedging transactions to mitigate foreign currency exchange rate risks, as its operations are primarily in the United States[122] - Interest rate changes are not expected to materially affect the company's financial position or cash flows, given the composition of its cash in bank deposits and short-term money market instruments[123] - The company assesses available-for-sale debt securities for credit loss, considering factors such as fair value relative to amortized cost and changes in security ratings[121] - Unrealized gains and losses on available-for-sale debt investments are recorded in accumulated other comprehensive income (AOCI)[120] - The company classifies its investments as current based on their nature and availability for use in operations[120] - The company measures stock-based compensation at grant date fair value, recognizing it as an expense over the requisite service period[118] - The company has updated all amounts and disclosures in its financial reports to comply with the new lease accounting standard[119]

Financial Data and Key Metrics Changes - First fiscal quarter revenue increased by 10% from $5.4 million to $6 million [4] - Income from operations rose by 28% to $1.9 million compared to $1.5 million [5] - GAAP net income increased by 13% to $1.8 million from $1.6 million [6][7] - Earnings per share for the quarter was $0.10 basic and $0.09 diluted, reflecting a year-over-year EPS growth of 13% [8] - Cash from operations decreased to $1.5 million from $1.9 million in the year-ago quarter [8] - Total cash increased to $28.8 million from $28.6 million, maintaining zero bank debt [8] Business Line Data and Key Metrics Changes - All lines of business are experiencing growth, with traditional sales and cross-selling initiatives contributing to accelerated momentum [9] - Revenue per employee is $356,000 annually, significantly higher than the industry average of $175,000 [5] Market Data and Key Metrics Changes - The company is positioned as a dominant player in the traceability and food safety sectors, leveraging its capabilities to grow across all business lines [15][22] - The traceability revenue continues to grow, enhancing the company's reputation in the industry [22] Company Strategy and Development Direction - The company aims to grow annual recurring revenue between 10%-20% and increase profitability at a faster rate [4] - A multi-year initiative to modernize the software code is underway, focusing on automation and AI to enhance operational efficiency [12][20] - The capital allocation strategy includes returning 50% of annual free cash flow to shareholders while maintaining a strong cash reserve [9][10] Management's Comments on Operating Environment and Future Outlook - The management acknowledges a cautious industry environment due to factors like government shutdowns and inflation, but the impact is not substantial [28] - The focus on data integrity and error correction in traceability is seen as a significant opportunity for future growth [30] Other Important Information - The company has redeemed approximately 572,000 shares of preferred stock and continues to repurchase common shares without incurring debt [10][11] - The modernization project is expected to drive significant efficiencies and create incremental value for customers and shareholders [22] Q&A Session Summary Question: How, if at all, were you impacted by the government shutdown? - The shutdown impacts the food industry due to the FDA not working, causing caution in the industry, but the impact is not substantial [28] Question: Do you still believe your by-ingredient efforts are increasing your total addressable market? - Yes, it expands the market as traceability records require participation from suppliers, creating a connected chain [29][32]

Core Insights - ReposiTrak has launched a "Touchless Traceability" solution aimed at distribution centers, addressing operational challenges in capturing and sharing lot codes and shipping data [1] Company Overview - ReposiTrak is recognized as the world's largest food traceability and regulatory compliance network [1] - The company utilizes its established inventory management and out-of-stock reduction SaaS platform to enhance its offerings [1] Industry Context - The introduction of the new traceability solution highlights the ongoing need for improved operational efficiency in distribution centers within the food industry [1]

[Executive Summary & Business Update](index=1&type=section&id=Executive%20Summary%20%26%20Business%20Update) ReposiTrak achieved significant revenue and net income growth in FY2025, driven by a strategic shift to a supplier-centric model and efficient operations [Fiscal Year 2025 & Q4 Highlights](index=1&type=section&id=Fiscal%20Year%202025%20%26%20Q4%20Highlights) ReposiTrak reported an 11% increase in full-year revenue to $22.6 million and a 17% increase in net income to $7.0 million for fiscal year 2025. Earnings per share grew by 21%. The company ended the fiscal year with a strong cash position of $28.6 million and no debt. Fourth-quarter results also showed an 11% revenue increase and 14% net income growth Full-Year Fiscal 2025 Financial Highlights: | Metric | FY2025 (Millions) | FY2024 (Millions) | Change (%) | | :-------------------------------- | :---------------- | :---------------- | :--------- | | Total Revenue | $22.6 | $20.5 | 11% | | Recurring Revenue (% of total) | ~99% | N/A | N/A | | Operating Expense | $16.4 | $15.4 | 6% | | Operating Income | $6.2 | $5.0 | 24% | | GAAP Net Income | $7.0 | $6.0 | 17% | | Net Income to Common Shareholders | $6.6 | $5.4 | 22% | | Basic EPS | $0.36 | $0.30 | 20% | | Diluted EPS | $0.35 | $0.29 | 21% | | Cash from Operations | $8.4 | $6.9 | 21% | | Cash at Year-End | $28.6 | N/A | N/A | | Bank Debt | $0 | N/A | N/A | Fourth Fiscal Quarter Financial Highlights: | Metric | Q4 FY2025 (Millions) | Q4 FY2024 (Millions) | Change (%) | | :-------------------------------- | :------------------- | :------------------- | :--------- | | Total Revenue | $5.8 | $5.2 | 11% | | Recurring Revenue (% of total) | ~99% | N/A | N/A | | Operating Expense | $4.2 | $3.9 | 8% | | Operating Income | $1.6 | $1.3 | 20% | | GAAP Net Income | $1.8 | $1.6 | 14% | | Net Income to Common Shareholders | $1.7 | $1.5 | 18% | | EPS | $0.09 | $0.08 | 12.5% | [CEO Commentary & Strategic Direction](index=1&type=section&id=CEO%20Commentary%20%26%20Strategic%20Direction) CEO Randall K. Fields highlighted a strategic shift from a hub-centric to a supplier-centric traceability model, which has increased engagement and expanded the addressable market. Investments in infrastructure and automation are improving efficiency, enabling growth without increasing headcount, and enhancing cross-selling opportunities. The company aims for 10-20% average annualized revenue growth and significantly greater profitability growth - ReposiTrak shifted from a hub-centric to a supplier-centric traceability model, solving problems for individual suppliers, which has increased engagement and expanded the addressable market for compliance and supply chain solutions[5](index=5&type=chunk) - The company invested in infrastructure to expand automation and accelerate customer onboarding, leading to increased revenue per employee and a greater number of deals without expanding headcount[5](index=5&type=chunk) - ReposiTrak maintains a goal of **10-20% average annualized revenue growth** and significantly greater growth in profitability, leveraging its efficient operational model and strong balance sheet[7](index=7&type=chunk) [Company Overview](index=3&type=section&id=Company%20Overview) ReposiTrak provides cloud-based solutions for risk management, compliance, and supply chain optimization to retailers, suppliers, and wholesalers [About ReposiTrak](index=3&type=section&id=About%20ReposiTrak) ReposiTrak (formerly Park City Group) provides cloud-based solutions for retailers, suppliers, and wholesalers to manage risk, ensure regulatory compliance, enhance operational controls, and increase sales. Its product families include food traceability, compliance and risk management, and supply chain solutions - ReposiTrak offers a robust solution suite to help retailers, suppliers, and wholesalers reduce risk, comply with regulations, enhance operational controls, and increase sales[15](index=15&type=chunk) - The company's integrated, cloud-based applications are categorized into three product families: food traceability, compliance and risk management, and supply chain solutions[15](index=15&type=chunk) [Detailed Financial Performance](index=2&type=section&id=Detailed%20Financial%20Performance) This section presents a comprehensive analysis of ReposiTrak's financial results for fiscal year 2025, including income statements, balance sheets, and cash flow statements [Full-Year Fiscal 2025 Financial Results](index=2&type=section&id=Full-Year%20Fiscal%202025%20Financial%20Results) For the full fiscal year ended June 30, 2025, ReposiTrak reported an 11% increase in total revenue to $22.6 million. Operating expenses rose by 6% to $16.4 million, while GAAP net income increased by 17% to $7.0 million. Net income attributable to common shareholders grew by 22% to $6.6 million, resulting in diluted EPS of $0.35 Full-Year Financial Results (YoY Comparison): | Metric | FY2025 (Millions) | FY2024 (Millions) | Change (%) | | :-------------------------------- | :---------------- | :---------------- | :--------- | | Total Revenue | $22.6 | $20.5 | 11% | | Total Operating Expense | $16.4 | $15.4 | 6% | | GAAP Net Income | $7.0 | $6.0 | 17% | | Net Income to Common Shareholders | $6.6 | $5.4 | 22% | | Diluted EPS | $0.35 | $0.29 | 21% | [Fourth Fiscal Quarter Financial Results](index=2&type=section&id=Fourth%20Fiscal%20Quarter%20Financial%20Results) In the fourth fiscal quarter ended June 30, 2025, total revenue increased 11% to $5.8 million. Total operating expense grew 8% to $4.2 million, with SG&A expense up 7% to $2.9 million. GAAP net income reached $1.8 million, and net income to common shareholders increased 18% to $1.7 million, translating to $0.09 per diluted share Fourth Fiscal Quarter Financial Results (YoY Comparison): | Metric | Q4 FY2025 (Millions) | Q4 FY2024 (Millions) | Change (%) | | :-------------------------------- | :------------------- | :------------------- | :--------- | | Total Revenue | $5.8 | $5.2 | 11% | | Total Operating Expense | $4.2 | $3.9 | 8% | | SG&A Expense | $2.9 | $2.7 | 7% | | GAAP Net Income | $1.8 | $1.6 | 14% | | Net Income to Common Shareholders | $1.7 | $1.5 | 18% | | Diluted EPS | $0.09 | $0.08 | 12.5% | [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) As of June 30, 2025, ReposiTrak maintained a strong balance sheet with $28.6 million in cash and cash equivalents and no bank debt. Total assets increased to $55.3 million from $51.6 million in the prior year, while total liabilities also increased to $5.8 million from $4.7 million. Total stockholders' equity grew to $49.5 million Consolidated Balance Sheet Highlights: | Metric | June 30, 2025 (Dollars) | June 30, 2024 (Dollars) | | :-------------------------------- | :---------------------- | :---------------------- | | Cash | $28,568,805 | $25,153,862 | | Total Current Assets | $33,685,800 | $29,300,167 | | Total Assets | $55,329,047 | $51,596,732 | | Total Current Liabilities | $5,531,118 | $4,543,142 | | Total Liabilities | $5,809,866 | $4,742,114 | | Total Stockholders' Equity | $49,519,181 | $46,854,618 | - The company reported **$28.6 million** in cash and cash equivalents at June 30, 2025, an increase from **$25.2 million** at June 30, 2024, and had no bank debt[13](index=13&type=chunk) [Consolidated Statements of Operations](index=5&type=section&id=Consolidated%20Statements%20of%20Operations) The Consolidated Statements of Operations show a robust increase in revenue and profitability for fiscal year 2025. Revenue grew to $22.6 million, leading to an income from operations of $6.2 million, up 24%. Net income reached $7.0 million, and diluted EPS was $0.35, reflecting strong operational efficiency and financial performance Consolidated Statements of Operations (FY2025 vs. FY2024): | Metric | FY2025 (Dollars) | FY2024 (Dollars) | | :-------------------------------- | :--------------- | :--------------- | | Revenue | $22,606,066 | $20,453,320 | | Total Operating Expense | $16,378,923 | $15,429,089 | | Income from Operations | $6,227,143 | $5,024,231 | | Net Income | $6,978,127 | $5,958,290 | | Net Income Applicable to Common Shareholders | $6,617,821 | $5,408,645 | | Basic Earnings Per Share | $0.36 | $0.30 | | Diluted Earnings Per Share | $0.35 | $0.29 | [Consolidated Statements of Cash Flows](index=6&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) Cash flows from operating activities significantly increased by 21% to $8.4 million in fiscal 2025, demonstrating strong operational cash generation. Investing activities resulted in a net cash inflow of $169, a notable improvement from a net outflow in the prior year. Financing activities used $5.0 million, primarily due to preferred share redemptions and dividends paid, leading to a net increase in cash and cash equivalents of $3.4 million Consolidated Statements of Cash Flows (FY2025 vs. FY22024): | Cash Flow Activity | FY2025 (Dollars) | FY2024 (Dollars) | | :-------------------------------- | :--------------- | :--------------- | | Net Cash Provided by Operating Activities | $8,420,132 | $6,964,401 | | Net Cash (Used in) Provided by Investing Activities | $169 | $(100,707) | | Net Cash Used in Financing Activities | $(5,005,358) | $(5,700,711) | | Net (Decrease) Increase in Cash and Cash Equivalents | $3,414,943 | $1,162,983 | | Cash and Cash Equivalents at End of Period | $28,568,805 | $25,153,862 | - Cash from operations increased **21% to $8.4 million** from $6.9 million last year, reflecting efficient operational performance[6](index=6&type=chunk) [Capital Allocation & Shareholder Returns](index=2&type=section&id=Capital%20Allocation%20%26%20Shareholder%20Returns) ReposiTrak demonstrates its commitment to shareholder value through preferred share redemptions, common share buybacks, and consistent dividend increases [Preferred Share Redemption](index=2&type=section&id=Preferred%20Share%20Redemption) ReposiTrak continued its program of returning capital to shareholders by redeeming 70,093 preferred shares for $749,995 in Q4 fiscal 2025. Cumulatively, the company has redeemed 501,679 preferred shares totaling $5.4 million, with an anticipated full redemption of remaining preferred shares by December 2026 - In Q4 FY2025, ReposiTrak redeemed **70,093 preferred shares for $749,995**. For the full fiscal year, **280,372 preferred shares were redeemed for $3 million**[6](index=6&type=chunk)[10](index=10&type=chunk) - Since inception, the company has redeemed **501,679 preferred shares for a total of $5.4 million**, with **$3.6 million** remaining to be redeemed by December 2026[10](index=10&type=chunk) [Common Share Buyback](index=2&type=section&id=Common%20Share%20Buyback) During fiscal 2025, ReposiTrak repurchased 8,681 common shares for approximately $200,033 at an average price of $23.13 per share. The company still has approximately $8 million remaining under its $21 million common share buyback authorization - During fiscal 2025, the Company repurchased **8,681 common shares for a total of $200,033**, at an average of **$23.13 per share**[11](index=11&type=chunk) - Approximately **$8 million** remains of the **$21 million** total common share buyback authorization[11](index=11&type=chunk) [Dividends](index=2&type=section&id=Dividends) The Board of Directors declared a quarterly dividend of $0.02 per share ($0.08 annually), payable around November 14, 2025. This marks the third 10% increase in ReposiTrak's dividend since its establishment, demonstrating a commitment to returning capital to shareholders - On September 19, 2025, the board declared a quarterly dividend of **$0.02 per quarter ($0.08 per share annually)**, representing the **third 10% increase** since the dividend was established[6](index=6&type=chunk)[12](index=12&type=chunk) - The cash dividends will be paid to shareholders of record on or about November 14, 2025, for those on record as of September 30, 2025[6](index=6&type=chunk)[12](index=12&type=chunk) [Corporate Information & Disclosures](index=2&type=section&id=Corporate%20Information%20%26%20Disclosures) This section provides essential corporate communications, forward-looking statements, and investor contact details [Conference Call Details](index=2&type=section&id=Conference%20Call%20Details) ReposiTrak hosted a conference call on September 29, 2025, at 4:15 p.m. ET to discuss the financial results. Details for live participation and replay access were provided, including dial-in numbers and a webcast link via the company's investor relations website - A conference call was hosted on Monday, September 29, 2025, at 4:15 p.m. ET to discuss the company's results, with a webcast available on www.parkcitygroup.com[14](index=14&type=chunk)[15](index=15&type=chunk) Conference Call Access Information: | Type | Detail | | :---------------- | :-------------------------------- | | Date | Monday, September 29, 2025 | | Time | 4:15 p.m. ET (1:15 p.m. PT) | | Toll-Free Dial-In | 1-877-407-9716 | | International Dial-In | 1-201-493-6779 | | Conference ID | 13755695 | | Replay Toll-Free | 1-844-512-2921 | | Replay International | 1-412-317-6671 | | Replay Expiry | Wednesday, October 29, 2025, 11:59 PM ET | [Forward-Looking Statement](index=3&type=section&id=Forward-Looking%20Statement) The document includes a standard forward-looking statement disclaimer, cautioning readers that any non-historical statements are subject to risks and uncertainties. It advises against undue reliance on these statements and refers to SEC filings for a discussion of risk factors - Statements not historical facts are forward-looking, identified by words like 'anticipate,' 'believe,' 'estimate,' and 'expect,' and are subject to change and material differences from final reported results[16](index=16&type=chunk) - Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of their making dates, and should refer to SEC filings for risk factors[16](index=16&type=chunk) [Investor Relations Contact](index=3&type=section&id=Investor%20Relations%20Contact) Contact information for investor relations is provided for inquiries, including the CFO's email and details for FNK IR - Investor relations inquiries can be directed to John Merrill, CFO, via investor-relations@repositrak.com, or to Rob Fink of FNK IR at 646.809.4048 or rob@fnkir.com[17](index=17&type=chunk)

Core Insights - ReposiTrak (NYSE: TRAK) is a leader in the food traceability and regulatory compliance sector, focusing on food safety and compliance with regulations [1] Financial Performance - On September 29, 2025, TRAK reported an earnings per share (EPS) of $0.09, matching estimates, but revenue was $5.76 million, below the expected $6.25 million [2][6] - Full-year revenue increased by 11% to $22.6 million, indicating a positive trend year-over-year [2][6] - Net income for the fiscal year rose by 17% to $7 million, showcasing strong financial health [3][6] Revenue Composition - TRAK's recurring revenue constitutes about 99% of total revenue, indicating a stable income stream [3] Valuation Metrics - The price-to-earnings (P/E) ratio is approximately 44.72, suggesting high investor confidence [4] - The price-to-sales ratio is around 13.74, and the enterprise value to sales ratio is about 12.50, reflecting strong sales performance [4] Liquidity and Financial Ratios - TRAK has a current ratio of about 6.03, indicating a robust ability to cover short-term liabilities [5] - The enterprise value to operating cash flow ratio is approximately 31.22, and the earnings yield is around 2.24%, providing insights into valuation and return on investment [5]